Women with type 2 diabetes get fewer cardioprotective drugs than do menSeptember 29, 2021DiabetesCardiologyWomen's Health
Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAsSeptember 27, 2021DiabetesEndocrinologyCardiology
Sexual assault in women tied to increased stroke, dementia riskSeptember 23, 2021Alzheimer's & CognitionWomen's HealthNeurologyCardiology
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinitionSeptember 20, 2021DiabetesCardiologyEndocrinology
A new weight loss threshold for T2d remission after bariatric surgery?September 20, 2021DiabetesObesityEndocrinologyCardiology
Premature menopause a ‘warning sign’ for greater ASCVD riskSeptember 17, 2021DiabetesWomen's HealthCardiology
Poor lung function linked to risk for sudden cardiac deathSeptember 16, 2021CardiologyPulmonologyPreventive Care
COVID vaccine preprint study prompts Twitter outrageSeptember 16, 2021COVID-19 UpdatesCardiologyVaccines
Texts boost activity, quality of life in patients with heart failure and diabetesSeptember 16, 2021DiabetesCardiology
Weight-loss surgery linked to fewer cardiovascular events, more so with RYGBSeptember 15, 2021ObesityDiabetesCardiologyGastroenterology
PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEFSeptember 14, 2021DiabetesObesityCardiologyEndocrinology
